.svg){kind=icon}
The endocannabinoid system may be one of the most important biological systems many people have never heard of.
Long before someone uses medical cannabis, the body is already producing its own cannabinoid-like signaling molecules. These naturally occurring compounds are part of the endocannabinoid system, or ECS—a complex network involved in communication between the brain, nervous system, immune system, digestive tract, and other tissues.
Two receptors receive much of the attention: CB1 and CB2.
Understanding what these receptors do can help Florida medical cannabis patients make sense of why THC, CBD, and even certain cannabis terpenes are studied for such a wide range of effects.
The important point is that CB1 and CB2 are not simple “on/off” switches. The ECS is a regulatory system, and cannabinoid effects depend on dose, product composition, administration route, individual biology, and the specific tissues involved.
What Is the Endocannabinoid System?
The endocannabinoid system is a signaling network found throughout the body.
Its major components include:
- Endocannabinoids produced naturally by the body
- Cannabinoid receptors
- Enzymes that produce and break down endocannabinoids
Two of the best-known endocannabinoids are anandamide, sometimes abbreviated AEA, and 2-arachidonoylglycerol, commonly called 2-AG.
These molecules can interact with cannabinoid receptors and help regulate signaling between cells.
Unlike many hormones that may be stored and released later, endocannabinoids are often produced when the body needs them and then broken down relatively quickly.
Researchers frequently describe the ECS as having a role in maintaining homeostasis, or internal balance.
What Does the Endocannabinoid System Regulate?
The ECS is involved in numerous physiological processes.
Research has connected endocannabinoid signaling with areas including:
- Appetite
- Pain processing
- Mood and stress
- Memory
- Sleep
- Movement
- Digestion
- Immune activity
- Inflammatory signaling
- Energy balance
- Neurological communication
That does not mean cannabis automatically improves all of these systems.
The ECS participates in these processes, but manipulating one part of the system may create both desired and unwanted effects.
This is one reason cannabinoid dosing matters.
What Are CB1 Receptors?
CB1 receptors are found at particularly high levels throughout the brain and central nervous system.
They are involved in signaling related to memory, appetite, pain perception, movement, reward, mood, and other neurological functions.
CB1 receptors also exist outside the brain, including in peripheral nerves and several organs and tissues.
THC interacts strongly with CB1 receptors. This activity helps explain many of THC's recognizable effects, including:
- Changes in perception
- Increased appetite
- Altered short-term memory
- Changes in coordination
- Changes in pain perception
- Euphoria or relaxation
- Anxiety in some individuals
Because CB1 receptors are highly involved in neurological signaling, increasing the THC dose can significantly change the patient experience.
A low or moderate amount may feel manageable, while a larger amount may cause dizziness, anxiety, sedation, impaired coordination, or uncomfortable intoxication.
Higher THC does not automatically mean better medical results.
What Are CB2 Receptors?
CB2 receptors are strongly associated with immune cells and peripheral tissues.
Researchers study CB2 signaling in connection with immune regulation, inflammation, tissue responses, and pain-related pathways.
CB2 receptors have also been identified within the nervous system, particularly under certain physiological or inflammatory conditions.
This makes the common shorthand useful—but incomplete:
CB1 = primarily brain and nervous system
CB2 = primarily immune and peripheral signaling
The real biology is more complicated.
Both receptors exist across multiple tissues, and their activity can change depending on health status and the surrounding biological environment.
How THC Interacts With CB1 and CB2
THC can activate both CB1 and CB2 receptors, although many of its psychoactive effects are associated with CB1 activity.
This helps explain why THC can influence several systems at the same time.
A patient may notice changes in appetite, mood, discomfort, coordination, and perception from the same product because cannabinoid signaling is occurring across multiple pathways.
Dose is critical.
More receptor activation is not necessarily better. Increasing THC may increase both desired effects and unwanted effects.
Patients should follow their physician-approved dosing plan rather than assuming that the product with the highest THC percentage is the most medically appropriate.
CBD Works Differently
CBD does not interact with CB1 receptors in the same direct manner as THC.
Instead, CBD influences several biological targets and may affect how the endocannabinoid system functions indirectly.
Researchers continue to study CBD's interaction with cannabinoid signaling, serotonin receptors, ion channels, enzymes, and other molecular systems.
This broader activity helps explain why describing CBD simply as “the cannabinoid that works on CB2” would be inaccurate.
CBD is also capable of interacting with prescription medications by affecting certain drug-metabolizing enzymes.
Patients using CBD alongside prescription medications should discuss potential interactions with a physician or pharmacist.
What About Cannabis Terpenes?
Cannabis terpenes are aromatic compounds responsible for many of the plant's recognizable scents and flavors.
Common examples include:
- Myrcene
- Limonene
- Pinene
- Linalool
- Humulene
- Beta-caryophyllene
Beta-caryophyllene is especially interesting in endocannabinoid research because it can interact with CB2 receptors.
That makes it different from many other commonly discussed terpenes.
However, finding beta-caryophyllene on a laboratory report does not mean that the product has been proven to treat inflammation, pain, or an immune-related condition.
Terpene profiles are useful for understanding and comparing products, but clinical effects should not be predicted from one terpene alone.
CB1 and CB2 Are Only Part of the Story
Modern cannabis research increasingly recognizes that the endocannabinoid system is more complex than two receptors.
Cannabinoids and endocannabinoids can influence other molecular targets, including certain ion channels and receptors outside the traditional CB1/CB2 system.
Researchers sometimes use the broader term endocannabinoidome to describe this expanded signaling network.
This is important because cannabis cannot be understood simply as:
THC activates CB1.
CBD activates CB2.
Terpenes create flavor.
The actual interactions are much more complex.
Cannabinoids, terpenes, dose, metabolism, administration route, tolerance, and individual physiology can all influence the final patient experience.
Green Dragon Florida Products to Compare
The following products represent different inhaled cannabis formats and cannabinoid concentrations. They are not treatments for a particular condition and are included as examples of how product composition and delivery method can differ.
Circles Flame Berry Flower — Coconut Creek
Circles Flame Berry Flower is a 3.5-gram hybrid flower currently listed at approximately 17.5% THC with around 1.11% total terpenes.
Flower allows patients to review a complete batch-specific cannabinoid and terpene profile rather than focusing on THC alone.
Everyday Green Goblin All-in-One — Lake Worth
Everyday Green Goblin All-in-One is a one-gram all-in-one vaporizer currently listed around 79.2% THC with approximately 5.51% total terpenes.
Its concentrated THC level illustrates why receptor biology and dose belong in the same conversation. A concentrated product can activate cannabinoid pathways with substantially less material than flower.
Green Dragon Pienana Preroll 14-Pack — Fort Pierce
Green Dragon Pienana Preroll 14-Pack contains fourteen prerolls totaling 7 grams.
Premeasured prerolls standardize the starting amount of flower in each unit, although the amount of THC actually absorbed still depends on how much is consumed and the patient's inhalation technique.
Product availability, potency, and laboratory information may vary by Green Dragon Florida location and batch.
The Green Dragon Takeaway
The endocannabinoid system is the biological foundation behind much of modern cannabis research.
CB1 receptors are especially prominent in the brain and nervous system and help explain many of THC's neurological and psychoactive effects. CB2 receptors are strongly associated with immune and peripheral signaling and are an important area of inflammation and cannabinoid research.
But neither receptor works alone.
The ECS includes naturally produced endocannabinoids, metabolic enzymes, additional molecular targets, and signaling pathways throughout the body.
For patients, the practical lesson is simple: cannabis effects depend on much more than THC percentage. Dose, cannabinoid profile, terpenes, administration route, tolerance, and personal biology all matter.